Study to Examine the Longer-Term Efficacy and Safety of Sibutramine Hydrochloride in Obese Subjects

Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian Population

NCT00677391 ·Status: COMPLETED ·Phase: PHASE3

A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese Subjects

NCT00134199 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Weight Loss Study in Overweight Men and Women

NCT00993421 ·Status: TERMINATED ·Phase: PHASE2

Studying the Effects of Sibutramine on Eating Behavior

NCT01170364 ·Status: TERMINATED ·Phase: PHASE4

Sibutramine-metformin Combination Versus Sibutramine and Metformin Monotherapy in Obese Patients

NCT00941382 ·Status: UNKNOWN ·Phase: PHASE3

A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects.

NCT00234988 ·Status: COMPLETED ·Phase: PHASE4

Pharmacodynamic Effects of Sibutramine on Gastric Function in Obesity

NCT00330525 ·Status: COMPLETED ·Phase: PHASE2

Sibutramine to Reduce Weight Gain and Improve Smoking Cessation Rates

NCT00037752 ·Status: COMPLETED ·Phase: NA

Efficacy of MK0557 in Combination With Sibutramine or Orlistat (0557-015)(COMPLETED)

NCT00533481 ·Status: COMPLETED ·Phase: PHASE2

A Study to Characterise the Physiology of Weight Loss and Regain Under Dietary, Behavioural and Pharmacological Interventions in Healthy Obese Subjects

NCT01597609 ·Status: COMPLETED ·Phase: PHASE1

A Comparative Study of KES524 in Patients With Obesity Disease

NCT00165685 ·Status: COMPLETED ·Phase: PHASE3

A Dose-ranging, Study of the Safety and Efficacy of Subcutaneous Injections of LIPO-102 Compared With Placebo for the Reduction of Abdominal Subcutaneous Adiposity

NCT01180465 ·Status: COMPLETED ·Phase: PHASE2

A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight

NCT05209984 ·Status: WITHDRAWN ·Phase: PHASE3

One-Year Study of S1B-509 vs Placebo for Weight Loss

NCT06517797 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 2)

NCT04897412 ·Status: COMPLETED ·Phase: PHASE2

Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet

NCT00748605 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

NCT06858839 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Effect of 2-year Administration of CP-945,598 on Weight Loss Efficacy and Safety.

NCT00396448 ·Status: TERMINATED ·Phase: PHASE3

Assess the Additional Weight Loss Effect of Orlistat Used in Combination With Sibutramine

NCT01184560 ·Status: COMPLETED ·Phase: NA

Phase Ib Clinical Study on the Efficacy and Safety of MDR-001 in Patients Who Are Obesity or Overweight

NCT07110766 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

A Study of Nasal PYY3-36 and Placebo for Weight Loss in Obese Subjects

NCT00537420 ·Status: COMPLETED ·Phase: PHASE2

A Study of Enicepatide (CT-388) in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity

NCT06525935 ·Status: COMPLETED ·Phase: PHASE2

A Long-Term Study To Examine The Effects Of CP-945,598 On Weight Loss And Safety

NCT00375401 ·Status: TERMINATED ·Phase: PHASE3

Deoxycholic Acid Injection Submental Fat (SMF) Magnetic Resonance Imaging (MRI) and Subject-reported Outcome Measures Study

NCT01032889 ·Status: COMPLETED ·Phase: PHASE2

Adolescent Weight Management Study

NCT00212173 ·Status: COMPLETED ·Phase: NA